Ridgeback Capital Investments L.P. Quant / Systematic

Name: Ridgeback Capital Investments L.P. Q4 2013 13F Filing | 13F Explorer
Creator: Ridgeback Capital Investments L.P.
Published: 2014-05-15

Location: Miami Beach, FL

CIK: 0001423994 · Show all filings

Period: Q4 2013 (← Previous) (Next →)

Filing Date: May 15, 2014

Total Value: $79.13M (100.0% shares, 0.0% debt)

Holdings (5)

SGMO SANGAMO BIOSCIENCES INC 50.9%

Value $40.28M Shares 2,900,000 Est. Cost $11.51 Unrealized 0.0%

— CELLDEX THERAPEUTICS INC 31.4%

Value $24.82M Shares 1,025,000 Est. Cost $6.71 Unrealized —

— STEMLINE THERAPEUTICS INC 12.6%

Value $9.931M Shares 506,699 Est. Cost $19.60 Unrealized —

— ARROWHEAD RESEARCH CORPORATION 3.8%

Value $3.031M Shares 279,361 Est. Cost $10.85 Unrealized —

GERN GERON CORPORATION 1.3%

Value $1.067M Shares 225,000 Est. Cost $4.29 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
SGMO	SANGAMO BIOSCIENCES INC	2,900,000	$40.28M	50.9%	$11.51	0.0%	Common Stock	800677106
—	CELLDEX THERAPEUTICS INC	1,025,000	$24.82M	31.4%	$6.71	—	Common Stock	15117B103
—	STEMLINE THERAPEUTICS INC	506,699	$9.931M	12.6%	$19.60	—	Common Stock	85858C107
—	ARROWHEAD RESEARCH CORPORATION	279,361	$3.031M	3.8%	$10.85	—	Common Stock	042797209
GERN	GERON CORPORATION	225,000	$1.067M	1.3%	$4.29	0.0%	Common Stock	374163103